Janssen
DARZALEX FASPRO
Manufacturer:
Janssen
Name:
DARZALEX FASPRO
Category:
J Code
HCPCS:
J9144
NDC(s):
57894-0503-01,
Primary Type:
Cancer
Route of Administration:
Subcutaneous
About:
DARZALEX FASPRO is a Cancer drug manufactured by Janssen and administered via the Subcutaneous route of administration. The J Code: J9144 is aligned to the drug DARZALEX FASPRO.